38 participants
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-03-29
- Start Date:
- 2018-02-15
- Completion:
- 2021-03-22
Conditions
- Relapsed/Refractory Multiple Myeloma
Interventions
- DRUG